Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hofstatter EW"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Increased epigenetic age in normal breast tissue from luminal breast cancer patients.
Autorzy:
Hofstatter EW; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA. erin.hofstatter@yale.edu.
Horvath S; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Dalela D; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.
Gupta P; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, 10065, USA.
Chagpar AB; Department of Surgery, Yale School of Medicine, 330 Cedar Street, New Haven, CT, 06511, USA.
Wali VB; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.
Bossuyt V; Department of Pathology, Yale School of Medicine, 330 Cedar Street, New Haven, CT, 06511, USA.
Storniolo AM; Department of Internal Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, 46202, USA.
Hatzis C; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.
Patwardhan G; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.
Von Wahlde MK; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.; Department of Obstetrics and Gynecology, Münster University Hospital, Münster, Germany.
Butler M; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.
Epstein L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.
Stavris K; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.
Sturrock T; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.
Au A; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.; Department of Clinical Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Kwei S; Department of Pharmacology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06511, USA.
Pusztai L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, 300 George Street, Suite 120, New Haven, CT, 06511, USA.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2018 Aug 29; Vol. 10 (1), pp. 112. Date of Electronic Publication: 2018 Aug 29.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
CpG Islands*
DNA Methylation*
Breast/*chemistry
Breast Neoplasms/*genetics
High-Throughput Nucleotide Sequencing/*methods
Adult ; Age Factors ; Case-Control Studies ; Epigenesis, Genetic ; Female ; Humans ; Middle Aged ; Sequence Analysis, DNA ; Tissue Banks
Czasopismo naukowe
Tytuł:
Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Autorzy:
Lam PB; Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, NRB 1030c, Boston, MA 02215, USA. />Burga LN
Wu BP
Hofstatter EW
Lu KP
Wulf GM
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2008 Dec 15; Vol. 7, pp. 91. Date of Electronic Publication: 2008 Dec 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*enzymology
Peptidylprolyl Isomerase/*metabolism
Receptor, ErbB-2/*metabolism
Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Humanized ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Down-Regulation/drug effects ; Humans ; Immunohistochemistry ; NIMA-Interacting Peptidylprolyl Isomerase ; Peptidylprolyl Isomerase/antagonists & inhibitors ; Peptidylprolyl Isomerase/deficiency ; Peptidylprolyl Isomerase/genetics ; Proteasome Inhibitors ; Protein Processing, Post-Translational/drug effects ; Protein Stability/drug effects ; Sirolimus/pharmacology ; Transcription, Genetic/drug effects ; Trastuzumab
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies